HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project

Michèle Beau-Faller 1 Erwan Pencreach 2 Charlotte Leduc 3 Hélène Blons 4 Jean-Philippe Merlio 5 Pierre-Paul Bringuier 6 Florence de Fraipont 7 Fabienne Escande 8 Antoinette Lemoine 9 l'Houcine Ouafik 10, 11 Marc Denis 12 Paul Hofman 13 Roger Lacave 14 Samia Melaabi 15 Alexandra Langlais 16 Pascale Missy 16 Franck Morin 16 Denis Moro-Sibilot 17 Fabrice Barlesi 18 Jacques Cadranel 19
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02483277
Contributor : l'Houcine Ouafik Connect in order to contact the contributor
Submitted on : Tuesday, February 18, 2020 - 3:18:51 PM
Last modification on : Wednesday, May 11, 2022 - 3:48:58 AM

Identifiers

Citation

Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, Hélène Blons, Jean-Philippe Merlio, et al.. Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer, Elsevier, 2020, 140, pp.19-26. ⟨10.1016/j.lungcan.2019.10.013⟩. ⟨hal-02483277⟩

Share

Metrics

Record views

34